Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Positron emission tomography imaging of cell proliferation in oncology.

Clinical oncology (Royal College of Radiologists (Great Britain)) - 1 May 2004

Kenny L M, Aboagye E O, Price P M

Abstract excerpt

Tumour-cell proliferation is a hallmark of the malignant phenotype. Positron emission tomography (PET) offers a unique method of imaging biological and biochemical changes in vivo. Radiolabelled thymidine and thymidine analogues are currently in development as PET tracers. By studying the uptake and kinetics of such compounds using PET, a measure of DNA synthesis and hence cell proliferation can be obtained....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cell Cycle
Share to Cyclins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dideoxynucleosides

Share to Kinetics

Share to Neoplasms

Share to Thymidine

Share to Tomography, Emission-Computed

Source

Identifiers

PMID: 15191004
DOI: 10.1016/j.clon.2003.10.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Positron emission tomography imaging of cell proliferation in oncology.PMID 15191004Read ↗

Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluationSemantic proximity Read ↗

Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.Semantic proximity Read ↗

Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity Read ↗

Assessment of cell proliferation by 5-bromodeoxyuridine (BrdU) labeling for multicolor flow cytometry.Semantic proximity Read ↗

Molecular tracers for the PET and SPECT imaging of diseaseSemantic proximity Read ↗

Positron emission tomographySemantic proximity Read ↗

2-[11C]Thymidine Positron Emission Tomography as an Indicator of Thymidylate Synthase Inhibition in Patients Treated With AG337Semantic proximity Read ↗

Design of radiolabelled ligands for the imaging and treatment of cancerSemantic proximity Read ↗

Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: Studies in vitro , in animals, and in humansSemantic proximity Read ↗

PET-based molecular imaging in neuroscienceSemantic proximity Read ↗

PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines.Semantic proximity Read ↗

The use of positron-emission tomography in the diagnosis of tumour phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.